Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C16H21NO |
| Molecular Weight | 243.344 |
| Optical Activity | ( - ) |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCCC[C@@]13CCN[C@@H]2CC4=CC=C(O)C=C34
InChI
InChIKey=IYNWSQDZXMGGGI-NUEKZKHPSA-N
InChI=1S/C16H21NO/c18-12-5-4-11-9-15-13-3-1-2-6-16(13,7-8-17-15)14(11)10-12/h4-5,10,13,15,17-18H,1-3,6-9H2/t13-,15+,16+/m0/s1
| Molecular Formula | C16H21NO |
| Molecular Weight | 243.344 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:29:27 UTC 2023
by
admin
on
Fri Dec 15 19:29:27 UTC 2023
|
| Record UNII |
IL94262N7K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
9634
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB09375MIG
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
100000083600
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
873
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
NORLEVORPHANOL
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | Norlevorphanol is an opioid analgesic of the morphinan class. It was never marketed. | ||
|
C054116
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
216-236-4
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
5463854
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
1531-12-0
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
C170233
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
CHEMBL2105152
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | |||
|
m8066
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY | Merck Index | ||
|
IL94262N7K
Created by
admin on Fri Dec 15 19:29:27 UTC 2023 , Edited by admin on Fri Dec 15 19:29:27 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
